Journal of Clinical Virology
Volume 35, Issue 2 , Pages 173-178 , February 2006

Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius

  • Sanjiv Rughooputh

      Affiliations

    • Molecular and Medical Microbiology Research Group, School of Biosciences, University of Westminster, 115, New Cavendish Street, London, W1 W6UW, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 911 5000x3690; fax: +44 207 911 5087.
    • ,
  • Rechad Eddoo

      Affiliations

    • Central Health Laboratory, Candos, Mauritius
    • ,
  • Shyam Manraj

      Affiliations

    • Central Health Laboratory, Candos, Mauritius
    • ,
  • Nilima Jeebun

      Affiliations

    • SSR Medical School, Belle Rive, Mauritius
    • ,
  • Pamela Greenwell

      Affiliations

    • Molecular and Medical Microbiology Research Group, School of Biosciences, University of Westminster, 115, New Cavendish Street, London, W1 W6UW, UK

Received 24 December 2003 ,Revised 11 March 2005 ,Accepted 15 March 2005.

References 

  1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410
  2. Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, et al. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer. 2004;108:258–261
  3. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346:1105–1112
  4. Chatterjee R, Mandal B, Bandyopadhyay S. Detection of HPV DNA in cervical carcinoma by PCR and hybrid capture assay. Indian J Pathol Microbiol. 2003;46:596–599
  5. Chatterjee R, Mukhopadhyay D, Murmu N, Jana S. Prevalence of human papillomavirus infection among prostitutes in Calcutta. J Environ Pathol Toxicol Oncol. 2001;20:113–117
  6. Crum CP, Mitao M, Levine RU, Silverstein S. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985;54:675–681
  7. Damasus-Awatai G, Freeman-Wang T. Human papilloma virus and cervical screening. Curr Opin Obstet Gynecol. 2003;15:473–477
  8. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res. 1990;50:6139–6145
  9. Evander M, Wadell G. A general primer pair for amplification and detection of genital human papillomavirus types. J Virol Methods. 1991;31:239–250
  10. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene. 2003;22:7233–7242
  11. Galloway DA. Papillomavirus vaccines in clinical trials. Lancet Infect Dis. 2003;3:469–475
  12. Hjerpe A, Lindh E, Bistoletti P, George J, Groff D. Use of cervical cytobrush samples for dot-blot detection and Southern Blot typing of human papillomaviruses using subgenomic probes. Anal Quant Cytol Histol. 1990;12:299–305
  13. Kailash U, Hedau S, Gopalkrishna V, Katiyar S, Das BC. A simple ‘paper smear’ method for dry collection transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. J Med Microbiol. 2002;51:606–610
  14. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, et al. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18 associated cervical and oral cancer in India. Mol Cell Biochem. 2003;252:117–124
  15. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol. 2003;71:265–273
  16. Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ, Kim SJ. The human papillomavirus E7 oncoprotein inhibits TGF-β signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem. 2002;277:38557–38564
  17. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus associated carcinomas in China. Cancer. 2002;95:2571–2576
  18. Manraj SS, Mustun H, Ghurburrun P, Laniece C, Salamon R. Cancer incidence in Mauritius (1989–1993). Bull Soc Pathol Exot. 1998;91:9–12
  19. Mans DR, Mohamedradja RN, Hoeblal AR, Rampadarath R, Joe SS, Wong J, et al. Cancer incidence in Suriname from 1980 through 2000 a descriptive study. Tumori. 2003;89:368–376
  20. Munoz N, Bosch XF. Cervical cancer and human papillomavirus: epidemiological evidence and perspectives for prevention. Salud Publica Mex. 1997;39:274–282
  21. Nagpal JK, Sahni S, Das BR. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus associated cervical cancer in Indian women. Eur J Clin Invest. 2002;32:943–948
  22. Ostrow RS, Bender M, Nimura M, Seki T, Kawashima M, Pass F, et al. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA. 1982;79:1634–1638
  23. Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S. Single copy heterozygote integration of HPV33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis. 2002;23:1057–1064
  24. Pillai MR, Sreevidya S, Pollock BH, Jayaprakash PG, Herma B. Polymorphism at codon 72 of p53, human papillomavirus and cervical cancer in south India. J Cancer Res Clin Oncol. 2002;128:627–631
  25. Plesa A, Anton G, Diaconu C, Stoian M, Repanovici R, Cernescu C. Cloning and expression of the L1 major capsid protein of the human papillomavirus 18 in murine cells. Int J Mol Med. 2003;12:1021–1026
  26. Rajkumar T, Franceschi S, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, et al. Role of paan chewing and dietary habits in cervical carcinoma in Chennai India. Br J Cancer. 2003;88:1388–1393
  27. Rughooputh S. Role of sexually transmitted organisms in the pathogenicity of cervical cancer. Ph.D. Thesis. University of Westminster; 2003.
  28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning : a laboratory manual. 2nd ed.. USA: Cold Spring Harbor; 1989;
  29. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127:930–934
  30. Tanara G, Falugi C, Cesario A, Margaritora S, Russo P, Cosimi A. TP53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from the Gambia. Int J Biol Markers. 2003;18:280–283
  31. Tripathi A, Banerjee S, Roy A, Roychowdhury S, Panda CK. Alterations of the P16 gene in uterine cervical carcinoma from Indian patients. Int J Gynecol Cancer. 2003;13:472–479
  32. Ting Y, Manos M. Detection and typing of genital human papillomaviruses. In:  Innis MA,  Gelfand DH,  Sninsky JJ,  White TJ editor. PCR protocols: a guide to methods and applications. New York, USA: Academic Press; 1990;p. 356–367
  33. Van Doorn LJ, Kleter B, Quint WG. Molecular detection and genotyping of human papillomavirus. Expert Rev Mol Diagn. 2001;1:394–402
  34. Wright TC, Schiffman M. Adding a test for human papillomavirus DNA to cervical cancer screening. N Engl J Med. 2003;348:489–490

PII: S1386-6532(05)00191-5

doi: 10.1016/j.jcv.2005.03.010

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 173-178 , February 2006

Article Tools